Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. Operating Income 2016–2025
Monopar Therapeutics Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Monopar Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -5.2 M, a 271.29% increase year-over-year.
- Monopar Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -8.3 M, a 51.41% decrease year-over-year.
- Monopar Therapeutics Inc. annual operating income for 2025 was -16.7 M, a 3.36% increase from 2024.
- Monopar Therapeutics Inc. annual operating income for 2024 was -16.2 M, a 273.79% increase from 2019.
- Monopar Therapeutics Inc. annual operating income for 2019 was -4.3 M, a 29.80% increase from 2018.
- Monopar Therapeutics Inc. annual operating income for 2018 was -3.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Monopar Therapeutics Inc. Operating Income — FAQ
Monopar Therapeutics Inc. (MNPR) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Monopar Therapeutics Inc.'s operating income?
Monopar Therapeutics Inc. (MNPR) reported operating income of -$17M for fiscal 2025.
Where can I see MNPR's operating income history?
The chart and table above show Monopar Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.